Androgen receptor gene status in plasma DNA associates with worse outcome on enzalutamide or abiraterone for castration-resistant prostate cancer: a multi-institution correlative biomarker study
Conteduca, V., Wetterskog, D., Sharabiani, M.T.A., Grande, E., Fernandez-Perez, M.P., Jayaram, A., Salvi, S., Castellano, D., Romanel, A., Lolli, C., Casadio, V., Gurioli, G., Amadori, D., Font, A., Vazquez-Estevez, S., González del Alba, A., Mellado, B., Fernandez-Calvo, O., Méndez-Vidal, M.J., Climent, M.A., Duran, I., Gallardo, E., Rodriguez, A., Santander, C., Sáez, M.I., Puente, J., Gasi Tandefelt, D., Wingate, A., Dearnaley, D., Demichelis, F., De Giorgi, U., Gonzalez-Billalabeitia, E., Attard, G.
Published in Annals of oncology (01.07.2017)
Published in Annals of oncology (01.07.2017)
Get full text
Journal Article
Grade group system and plasma androgen receptor status in the first line treatment for metastatic castration resistant prostate cancer
Cursano, M C, Conteduca, V, Scarpi, E, Gurioli, G, Casadei, C, Gargiulo, S, Altavilla, A, Lolli, C, Vincenzi, B, Tonini, G, Santini, D, De Giorgi, U
Published in Scientific reports (05.05.2022)
Published in Scientific reports (05.05.2022)
Get full text
Journal Article
Androgen receptor gain in circulating free DNA and splicing variant 7 in exosomes predict clinical outcome in CRPC patients treated with abiraterone and enzalutamide
Del Re, M, Conteduca, V, Crucitta, S, Gurioli, G, Casadei, C, Restante, G, Schepisi, G, Lolli, C, Cucchiara, F, Danesi, R, De Giorgi, U
Published in Prostate cancer and prostatic diseases (01.06.2021)
Published in Prostate cancer and prostatic diseases (01.06.2021)
Get full text
Journal Article
Circulating androgen receptor combined with 18F-fluorocholine PET/CT metabolic activity and outcome to androgen receptor signalling-directed therapies in castration-resistant prostate cancer
Conteduca, V, Scarpi, E, Caroli, P, Salvi, S, Lolli, C, Burgio, S L, Menna, C, Schepisi, G, Testoni, S, Gurioli, G, Paganelli, G, Casadio, V, Matteucci, F, De Giorgi, U
Published in Scientific reports (14.11.2017)
Published in Scientific reports (14.11.2017)
Get full text
Journal Article
Longitudinal assessment of plasma androgen receptor copy number predicts overall survival in subsequent treatment lines in castration-resistant prostate cancer: analysis from a prospective trial
Brighi, N., Conteduca, V., Gurioli, G., Scarpi, E., Cursano, M.C., Bleve, S., Lolli, C., Schepisi, G., Casadei, C., Gianni, C., Ulivi, P., De Giorgi, U.
Published in ESMO open (01.12.2023)
Published in ESMO open (01.12.2023)
Get full text
Journal Article
Impact of metabolic syndrome on clinical outcome of castration resistant prostate cancer (CRPC) patients treated with abiraterone and enzalutamide
Conteduca, V, Caffo, O, Galli, L, Maugeri, A, Scarpi, E, Maines, F, Chiuri, V E, Lolli, C, Kinspergher, S, Schepisi, G, Santoni, M, Santini, D, Fratino, L, Burgio, S L, Salvi, S, Menna, C, de Giorgi, U
Published in Annals of oncology (01.10.2017)
Published in Annals of oncology (01.10.2017)
Get full text
Journal Article
2577 The correlation between circulating cell-free AR and CYP17A1 copy number variations and tumor burden estimated by 18F-fluorocholine PET/CT in metastatic castration-resistant prostate cancer patients treated with abiraterone
Conteduca, V, Salvi, S, Caroli, P, Scarpi, E, Lolli, C, Burgio, S.L, Menna, C, Schepisi, G, Bianchi, E, Gurioli, G, Paganelli, G, Casadio, V, Matteucci, F, Attard, G, De Giorgi, U
Published in European journal of cancer (1990) (01.09.2015)
Published in European journal of cancer (1990) (01.09.2015)
Get full text
Journal Article
Severe esophagitis in a patient with gastrointestinal stromal tumor treated with imatinib
Saponara, M., Di Battista, M., Lolli, C., Pantaleo, M. A., Azzaroli, F., Santini, D., Di Scioscio, V., Catena, F., Astorino, M., Maleddu, A., Biasco, G.
Published in Endoscopy (2009)
Published in Endoscopy (2009)
Get full text
Journal Article
1809P Dynamics of plasma tumour DNA and copy number alterations in advanced metastatic castration-resistant prostate cancer (mCRPC) patients treated with cabazitaxel: A prospective biomarker trial
Brighi, N., Wetterskog, D., Gurioli, G., Orlando, F., Conteduca, V., Casadei, C., Lolli, C., Giunta, E.F., Bleve, S., Vainauskas, O., Basso, U., Pierantoni, F., Fornarini, G., Mosca, A., Nicodemo, M., Banna, G.L., Ulivi, P., Demichelis, F., De Giorgi, U.F.F., Attard, G.
Published in Annals of oncology (01.10.2023)
Published in Annals of oncology (01.10.2023)
Get full text
Journal Article
1826P Lutetium-177-PSMA in pre- and post-taxane mCRPC setting: Results from a phase II clinical trial
Giunta, E.F., Sansovini, M., Grassi, I., Marini, I., Brighi, N., Lolli, C., Schepisi, G., Nicolini, S., Foca, F., Monti, M., Celli, M., Caroli, P., Di Iorio, V., Sarnelli, A., Severi, S., Paganelli, G., Matteucci, F., De Giorgi, U.F.F.
Published in Annals of oncology (01.10.2023)
Published in Annals of oncology (01.10.2023)
Get full text
Journal Article
601P The prognostic role of longitudinal assessment of plasma androgen receptor (AR) copy number (CN) in metastatic castration-resistant prostate cancer (mCRPC): Analysis from a prospective biomarkers trial
Brighi, N., Conteduca, V., Gurioli, G., Scarpi, E., Lolli, C., Schepisi, G., Casadei, C., Bleve, S., Ulivi, P., De Giorgi, U.
Published in Annals of oncology (01.09.2021)
Published in Annals of oncology (01.09.2021)
Get full text
Journal Article
LBA71 Open-label, multicentre randomised trial of Radium223-docetaxel versus docetaxel-Radium223 sequence in metastatic castration resistant prostate cancer (mCRPC) with prospective biomarker evaluation (RAPSON study)
Conteduca, V., Brighi, N., Gurioli, G., Wetterskog, D., Giunta, E.F., Lolli, C., Schepisi, G., Chiuri, V.E., Gasparro, D., Zucali, P.A., Virga, A., Bondi, I., Vertogen, B., Di Iorio, V., Sansovini, M., Severi, S., Scarpi, E., Urbini, M., Attard, G., De Giorgi, U.
Published in Annals of oncology (01.09.2024)
Published in Annals of oncology (01.09.2024)
Get full text
Journal Article
868PSafety of new androgen receptor inhibitors (ARi) in patients with nonmetastatic castration-resistant prostate cancer (nmCRPC): A network meta-analysis of randomized controlled trials (RCT)
Altavilla, A, Maio, M Di, Tucci, M, Lolli, C, Schepisi, G, Buttigliero, C, Vignani, F, Giorgi, U De
Published in Annals of oncology (01.10.2019)
Published in Annals of oncology (01.10.2019)
Get full text
Journal Article
Safety of new androgen receptor inhibitors (ARi) in patients with nonmetastatic castration-resistant prostate cancer (nmCRPC): A network meta-analysis of randomized controlled trials (RCT)
Altavilla, A., Maio, M Di, Tucci, M., Lolli, C., Schepisi, G., Buttigliero, C., Vignani, F., De Giorgi, U.
Published in Annals of oncology (01.10.2019)
Published in Annals of oncology (01.10.2019)
Get full text
Journal Article
868P - Safety of new androgen receptor inhibitors (ARi) in patients with nonmetastatic castration-resistant prostate cancer (nmCRPC): A network meta-analysis of randomized controlled trials (RCT)
Altavilla, A., Maio, M Di, Tucci, M., Lolli, C., Schepisi, G., Buttigliero, C., Vignani, F., De Giorgi, U.
Published in Annals of oncology (01.10.2019)
Published in Annals of oncology (01.10.2019)
Get full text
Journal Article
Retrograde perfusion sphinterometry to evaluate efficacy of autologous 6-branch suburethral sling to properly restore sphincteric apparatus during robotic assisted radical prostatectomy (RALP)
Cestari, A, Lolli, C, Ghezzi, M, Sangalli, M, Zanoni, M, Fabbri, F, Sozzi, F, Zanni, G, Dell’Acqua, V, Rigatti, P
Published in European urology supplements : official journal of the European Association of Urology (01.03.2017)
Published in European urology supplements : official journal of the European Association of Urology (01.03.2017)
Get full text
Journal Article
615P Circulating tumor cells (CTC) gene expression and plasma androgen receptor (AR) copy number (CN) in cabazitaxel-treated metastatic castration-resistant prostate cancer (mCRPC)
Gurioli, G., Conteduca, V., Brighi, N., Scarpi, E., Basso, U., Fornarini, G., Mosca, A., Nicodemo, M., Banna, G.L., Lolli, C., Schepisi, G., Ravaglia, G., Ulivi, P., De Giorgi, U.
Published in Annals of oncology (01.09.2021)
Published in Annals of oncology (01.09.2021)
Get full text
Journal Article
583P Baseline plasma tumour DNA (ptDNA) correlates with PSA kinetics in metastatic castration-resistant prostate cancer (mCRPC) treated with abiraterone or enzalutamide
Conteduca, V., Scarpi, E., Wetterskog, D., Brighi, N., Schepisi, G., Romanel, A., Casadei, C., Lolli, C., Gurioli, G., Toma, I., Poti, G., Farolfi, A., Demichelis, F., Attard, G., De Giorgi, U.
Published in Annals of oncology (01.09.2021)
Published in Annals of oncology (01.09.2021)
Get full text
Journal Article